Review Article| Volume 29, ISSUE 3, P561-571, September 2009

Point-of-Care Testing for Cardiac Markers in Acute Coronary Syndromes and Heart Failure


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Collinson P.
        Testing for cardiac markers at the point of care.
        Clin Lab Med. 2001; 21: 351-362
        • Wu A.
        Point of care testing for cardiac markers: has the time come.
        Point of Care. 2002; 1: 39-61
        • Blomkalns A.
        Point of care testing for ACS in the emergency department. Emergency Medicine Cardiac Research and Education Group monograph.
        in: Blomkalns A. Gibler B. American College of Emergency Physicians Scientific Assembly Satellite Symposium. College of American Pathologists, Chicago IL2005 (Available at:
        • Ming S.
        • Padma K.
        • Morissey R.
        • et al.
        Ninety minute accelerated critical pathway for chest pain evaluation.
        Am J Cardiol. 2001; 88: 611-616
        • Dadkhah S.
        • Sharain K.
        • Sharain R.
        • et al.
        The value of bedside cardiac multimarker assay in rapid and accurate diagnosis of acute coronary syndromes.
        Crit Pathw Cardiol. 2007; 6: 76-84
        • Alpert J.
        • Antman E.
        • Apple F.
        • et al.
        Myocardial infarction redefined. A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
        J Am Coll Cardiol. 2000; 36: 959-969
        • Puleo P.
        • Meyer D.
        • Wathen C.
        • et al.
        Use of a rapid assay of subforms of creatinine kinase MB to diagnose or rule out acute myocardial infarction.
        N Engl J Med. 1994; 331: 561-566
        • Hamm C.
        Cardiac biomarkers for rapid evaluation of chest pain.
        Circulation. 2001; 104: 1454-1459
        • Lee-Lewandrowski E.
        • Corboy D.
        • Lewandrowski K.
        • et al.
        Implementation of a point of care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay.
        Arch Pathol Lab Med. 2003; 127: 456-460
        • McCord J.
        • Nowak R.
        • McCullough P.
        • et al.
        Ninety minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I (CHECKMATE) study.
        Circulation. 2001; 103: 1832-1837
        • Di Serio F.
        • Antonelli G.
        • Trerotoli P.
        • et al.
        Appropriateness of point of care testing (POCT) in an emergency department.
        Clin Chim Acta. 2003; 333: 185-189
        • Apple F.
        • Chung A.
        • Kogut M.
        • et al.
        Decreased patient charges following implementation of point of care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit.
        Clin Chim Acta. 2006; 370: 191-195
        • Ryan R.
        • Linsell C.
        • Hollander J.
        • et al.
        A multicenter randomized controlled trial comparing central laboratory and point of care cardiac marker testing strategies: the disposition impacted by serial point of care markers in acute coronary syndromes (DISPO-ACS) trial.
        Ann Emerg Med. 2008; ([epublication ahead of print])
      1. Storrow A. A systematic review of emergency department point-of-care cardiac markers and ED efficiency measures. Point of Care, in press.

        • Apple F.
        • Jesse R.
        • Newby K.
        • et al.
        National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes.
        Clin Chem. 2007; 53: 547-551
        • Lee-Lewandrowski E.
        • Benzer T.
        • Corboy D.
        • et al.
        Cardiac marker testing as part of an emergency department point-of-care satellite laboratory in a large academic medical center. Practical issues concerning implementation.
        Point of Care. 2002; 1: 145-154
        • Casals G.
        • Filella X.
        • Auge J.
        • et al.
        Impact of ultrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction.
        Am J Clin Pathol. 2008; 130: 964-998
        • Lusky K.
        Troponin: new tool in an old friend.
        CAP Today. 2009; 23: 1-17
        • Morrow D.
        • deLemos J.
        • Sabatine M.
        • et al.
        The search for a biomarker of ischemia.
        Clin Chem. 2003; 49 ([editorial]): 537-539
        • Apple F.
        • Wu A.
        • Mair J.
        • et al.
        Future biomarkers of ischemia and risk stratification in acute coronary syndrome.
        Clin Chem. 2005; 51: 810-824
        • Maisel A.
        • Bhalla V.
        • Braunwald E.
        Cardiac biomarkers: a contemporary status report.
        Nat Clin Pract Cardiovasc Med. 2006; 3: 24-34
        • deFilippi C.
        Natriuretic peptides for diagnosing heart failure and beyond: what we know in 2007. Medscape continuing medical education 2007 (May).
        (Available at:) (Accessed May 24, 2007)
        • Januzzi J.
        • Camargo C.
        • Anwaruddin S.
        • et al.
        The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
        Am J Cardiol. 2005; 95: 948-954
        • Mueller C.
        • Scholer A.
        • laule K.
        • et al.
        Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.
        N Engl J Med. 2004; 350: 647-654
        • Clerico A.
        • Fontana M.
        • Passino C.
        • et al.
        Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure.
        Clin Chem. 2007; 53: 813-822
        • Green S.
        • Redmond K.
        • Januzzi J.
        • et al.
        The impact of amino-terminal pro-brain natriuretic peptide testing on hospital length of stay and morbidity in patients with acute heart failure.
        Arch Pathol Lab Med. 2007; 131: 473-476
        • Blick K.
        Economics of point-of-care testing for cardiac markers and B-natriuretic peptide (BNP).
        Point of Care. 2005; 4: 11-14
        • Breidthardt T.
        • Laule K.
        • Strohmeyer A.
        • et al.
        Medical and economic long term effects of B-type natriuretic peptide testing in patients with acute dyspnea.
        Clin Chem. 2007; 53: 1415-1422
        • Jourdain P.
        • Jondeau G.
        • Funck F.
        • et al.
        Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.
        J Am Coll Cardiol. 2007; 49: 1733-1739